ClosedSMENutraceuticals / Health & Wellness · Nutritional Products & Supplements
Accretion Nutraveda
ANL·₹129·Opens 2026-01-28
★★★★☆4/5
🔗 Official WebsiteSubscribed
1.77×
Overall
Price Band: ₹129
Min. Investment: 200000
Issue Size: —
About the Company
What does this company do?
Accretion Nutraveda Limited is engaged in the business of manufacturing and distribution of nutraceutical and nutritional products including vitamins, minerals, amino acids, and other dietary supplements for healthcare and wellness purposes.
IPO Details
Issue parameters, key dates and structure.
Reservation Structure
QIB (Qualified Institutional Buyers)
50
Up to 60% of QIB portion reserved for Anchor Investors
NII / HNI (Non-Institutional Investors)
15
Not less than 15% of Net Issue
RII (Retail Individual Investors)
35
Not less than 35% of Net Issue
Financial Performance
P&L, Balance Sheet and Cash Flow — all figures in ₹ Crores.
| Particulars (₹ Cr) | FY2025 |
|---|
All figures in ₹ Crores (INR). Data sourced from DRHP/RHP.
Key Financial Ratios
Valuation and profitability metrics at the IPO price.
EPS — Basic (₹)
—
FY2025
EPS — Diluted (₹)
—
FY2025
P/E Ratio
—
At upper band
RoNW (%)
—
FY2025
NAV per Share (₹)
—
Pre-issue
Peer Comparison
Listed peers in the same industry — compare valuation and scale.
| Company | Exchange | Market Cap | Revenue (₹ Cr) | PAT (₹ Cr) | P/E | ROE |
|---|---|---|---|---|---|---|
| Walpar Nutrition Limited | NSE | — | 6016.16 | 169.26 | — | 11.94 |
| Influx Healthtech Limited | NSE | — | 10485.36 | 1327.32 | — | 44.98 |
* Peer data extracted from DRHP. All figures in ₹ Crores unless stated. P/E based on latest available earnings.
SWOT Analysis
Internal strengths & weaknesses; external opportunities & threats.
💪Strengths
Strong revenue growth trajectory with 219.70% YoY growth
High profitability margins (EBITDA 22.79%, PAT 16.33%)
Experienced management team with industry expertise
Positive cash generation from operations
⚠️Weaknesses
Relatively smaller scale compared to established peers
High leverage with debt/equity ratio of 0.72
Limited market presence and brand awareness
🚀Opportunities
Growing health and wellness market in India
Increasing consumer awareness about preventive healthcare
Expansion into new product categories and geographies
E-commerce and direct-to-consumer channels growth
🔥Threats
Intense competition from larger, established players
Regulatory changes in nutraceutical sector
Supply chain disruptions and raw material price volatility
Price competition leading to margin pressure
Competitive Strengths
Key advantages highlighted in the DRHP.
✓
Strong revenue growth of 219.70% YoY in FY2025 with consistent expansion trajectory
✓
High profitability with PAT margin of 16.33% and EBITDA margin of 22.79% in FY2025
✓
Experienced promoter team with deep industry expertise in nutraceuticals sector
✓
Healthy balance sheet with net worth of 534.87 crores and positive cash flow generation
✓
Growing domestic demand for nutraceutical products with increasing health consciousness among consumers
Promoters & Shareholding
Pre & post-IPO shareholding pattern. Click a promoter card to learn more.
Promoters
Shareholding Pattern
10073.48%
026.52%
PrePost
Key Risks
Material risk factors to consider before applying.
⚠
Intense competition in nutraceuticals industry from established players and new entrants
⚠
Regulatory changes in health supplement regulations and product approvals
⚠
Dependence on raw material sourcing and supply chain disruptions
⚠
Risk of product recalls or quality issues affecting brand reputation
⚠
Price sensitivity in retail segment with margin compression risks
◆ Subscribe for Listing Gains
Should You Apply?
Accretion Nutraveda Limited is a growing nutraceutical company with strong revenue growth of 219.70% in FY2025 and healthy profitability margins (EBITDA 22.79%, PAT 16.33%). The company benefits from the rising health and wellness consumption trend in India. At the issue price of ₹129, the valuation appears reasonable given the strong growth trajectory and improving RoNW of 81.22%. The company is suitable for investors seeking exposure to the growing nutraceuticals sector with potential for capital appreciation.
⚠️ This is not investment advice. CheckIPO provides information for educational purposes only. Always consult a SEBI-registered financial advisor before investing.
IPO Timeline
Key milestones from opening to listing.
📅
IPO Opens
2026-01-28
🔒
IPO Closes
2026-01-30
🏛️
Listing
2026-02-03
Lead Managers & Registrar
Institutions managing the issue and handling allotment.
Book Running Lead Managers (1)
Sobhagya Capital Options
Registrar to the Issue
📋
KFin Technologies Limited
Registrar to the Issue
Company Details
Registered information and contact details.
Company Name
Accretion Nutraveda Limited
CIN
U24290GJ2021PLC121216
Registered Office
27 Xcelon Industrial Park-1, Vasna-Chacharwadi, Ta-Sanand, Ahmedabad, Gujarat, India, 382213
Contact Person
Ms. Payal Hareshbhai Kotadiya
Phone
+91-9904366177
Website
www.accretionnutraveda.com